myirislogo
29 March, 2015 16:07 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 263.55 2.59
Axis Bank 546.05 0.36
Icici Bank 314.40 2.23
Tata Stl 315.00 0.24
I T C 317.10 1.72
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Suven Life Sciences Limited
Suven Life Sciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530239NSE:SUVENBloomberg:SVLS@INReuters:SUVP.BO
Market Lot: 1Face Value: 1ISIN Demat: INE495B01038
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
24-MAR-15 Suven Life Sciences announced that it has bagged three product patents for their New Chemical Entities (NCEs) in Canada, Japan and Korea. 16-MAR-15 Suven Life Sciences, a biopharmaceutical company, announced today that they secured patents in USA (8912179) and New Zealand (614567) to one of their New Chemical Entity (NCE) for CNS therapy through new mechanism of action-H3 Inverse agonist and these patents are valid until 2030 and 203...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Suven Life bags three product patents for NCEs  -IRIS 24-Mar-15
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2014(9)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 4101.935103.122578.85
Other Income47.7030.3010.43
Total Income4149.635133.422589.28
Cost of goods sold2655.922912.542046.99
OPBDIT1493.712220.88542.29
PAT918.021441.58308.40
Gross Block---
Equity capital127.28116.83116.83
EPS (Rs.)-12.342.64
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-1.78 - 6.765.09 - 13.35
Debt / Equity (x)---
Operating margin (% of OI)36.043.320.9
Net margin (% of OI)22.128.111.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
SDE Serene Chambers
Road No 5
Banjara Hills
Hyderabad
Andhra Pradesh-500 034
PHONE
(040) 2354 1142/ 3311
FAX
(040) 2354 1152
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer